📊 statistics

DiPPER: A Bayesian approach to differential prevalence analysis with applications in microbiome studies

The paper introduces DiPPER, a Bayesian hierarchical modeling method for differential prevalence analysis in microbiome studies that outperforms existing approaches by demonstrating high sensitivity, well-calibrated error rates, and superior cross-study replication while inherently adjusting for multiple testing.

Original authors: Juho Pelto, Kari Auranen, Janne V. Kujala, Leo Lahti

Published 2026-05-26

📖 5 min read🧠 Deep dive

CC BY 4.0

Original authors: Juho Pelto, Kari Auranen, Janne V. Kujala, Leo Lahti

Original paper licensed under CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). ✨ This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer

Imagine you are a detective trying to solve a mystery: Which specific bacteria are showing up in sick people but not in healthy people?

In the world of microbiome research (studying the tiny organisms living in our guts), scientists have traditionally tried to count exactly how many of each bacteria are present. But this paper argues that sometimes, simply knowing if a bacteria is there or not (present/absent) is actually a better, more reliable clue than counting the exact numbers.

To help researchers find these "present vs. absent" clues, the authors created a new tool called DiPPER.

Here is a simple breakdown of what the paper says, using everyday analogies:

1. The Problem: The "All-or-Nothing" Trap

Imagine you are looking at a room full of people. You want to know if a specific person, "Bob," is in the room.

The Old Way (Frequentist Methods): You try to calculate the odds. But if Bob is either completely missing from the room or standing right in the center of it, the math breaks down. The old tools often say, "I can't calculate this," or they give you a very shaky, wide guess.
The Multiple Testing Nightmare: You are checking for 500 different people (bacteria) at once. If you just check them one by one, you might accidentally think you found a "sick person" just by pure luck. To fix this, old methods use a "brute force" correction (like the Bonferroni correction) that makes the rules so strict you might miss real clues. It's like using a sledgehammer to crack a nut; it stops the mistakes, but it also crushes the good answers.

2. The Solution: DiPPER (The Smart Detective)

The authors built DiPPER (Differential Prevalence via Probabilistic Estimation in R). Instead of checking each bacteria in isolation, DiPPER uses a Bayesian Hierarchical Model.

The Analogy: The "Classroom" Approach
Imagine you are trying to guess the height of every student in a large school.

The Old Way: You measure each student individually. If a student is very short or very tall (a "boundary case"), your ruler might break or give a weird number.
DiPPER's Way: DiPPER looks at the whole class first. It learns the general "shape" of the class (e.g., "Most students are average height, but a few are very tall or very short"). Then, when it looks at a specific student, it uses that group knowledge to make a smarter guess.
- If a student is an extreme outlier (like a bacteria that is 100% present in sick people and 0% in healthy people), DiPPER doesn't get confused. It uses the "group knowledge" to give a solid, finite answer.
- It also naturally handles the "multiple testing" problem. Because it learns from the whole group, it doesn't need to use the "brute force" sledgehammer. It adjusts its own confidence levels automatically.

3. The Secret Ingredient: The "Asymmetric" Prior

The paper mentions a specific mathematical trick called an asymmetric Laplace distribution.

The Metaphor: Imagine a bell curve (the standard shape of data). Usually, we assume that if a bacteria is different in sick vs. healthy people, it's just as likely to be more common in sick people as it is to be less common.
DiPPER's Insight: The authors noticed that in real microbiome studies, things aren't perfectly balanced. Often, if a group of bacteria changes, they tend to change in the same direction (e.g., they all get more common in sick people).
DiPPER uses a "lopsided" bell curve that expects this imbalance. This makes it much better at spotting real patterns than tools that assume everything is perfectly symmetrical.

4. The Results: How Did It Do?

The authors tested DiPPER against 7 other popular methods using data from 57 different human gut microbiome studies (covering diseases like colorectal cancer, diabetes, and obesity).

The "False Alarm" Test: They created fake datasets where no bacteria were actually different.
- Result: DiPPER was very good at not raising false alarms. It stayed right at the expected error rate (10%), whereas some other tools were too conservative (missing real things) or too loose (raising too many false alarms).
The "Replication" Test: This is the most important part. If a tool finds a clue in Study A, does it find the same clue in Study B?
- Result: DiPPER was the champion. It found more clues that could be successfully repeated in other independent studies than any other method. It was better at finding the "real" biological signals and ignoring the noise.
The "Boundary" Test: When bacteria were 0% or 100% present (the cases where old math tools fail), DiPPER kept working and gave clear answers. The old tools often just gave up or said "N/A."

5. What About "Abundance" (Counting)?

The paper also briefly tested if this "group-learning" approach could work for counting bacteria (Differential Abundance Analysis) instead of just checking presence.

Result: It showed promise and performed well, but the authors warn that this specific application needs more testing before it's widely adopted. The main focus and proven success of DiPPER is on presence/absence (prevalence).

Summary

DiPPER is a new, smarter way to analyze microbiome data. Instead of treating every bacteria as an isolated math problem that often breaks at the edges, it treats them as a team. By looking at the group to understand the individual, it avoids common math errors, handles extreme cases gracefully, and is much better at finding clues that are actually real and repeatable across different studies.

Where to find it: The code is open-source and available on GitHub for anyone to use.

Technical Summary of DiPPER: A Bayesian approach to differential prevalence analysis

Problem Statement
Recent evidence suggests that analyzing the presence/absence of taxonomic features offers a compelling alternative to differential abundance analysis (DAA) in microbiome studies, as machine learning classifiers can maintain performance using binary data and many abundance signals are driven primarily by prevalence differences. However, standard approaches to differential prevalence analysis (DPA), typically based on frequentist logistic regression, face significant limitations. These include:

Boundary Cases: Standard methods (e.g., Wald test, likelihood ratio test) often fail to yield finite point estimates, confidence intervals, or p-values when a feature has 0% or 100% prevalence in one group, a common occurrence in microbiome datasets.
Multiple Testing: Detecting differentially prevalent features among thousands of candidates requires post-hoc adjustments (e.g., Benjamini-Hochberg) to control false discovery rates. While these control false positives, they often increase false negatives and do not straightforwardly extend to point estimates or confidence intervals.
Asymptotic Approximations: Reliance on asymptotic approximations for p-values and intervals can lose accuracy in boundary cases typical of microbiome data.

Methodology: DiPPER
The authors introduce DiPPER (Differential Prevalence via Probabilistic Estimation in R), a Bayesian hierarchical modeling framework designed to address these limitations.

Model Structure: The method models the observed presence ( $y_{ij}=1$ ) or absence ( $y_{ij}=0$ ) of feature $j$ in sample $i$ using a logistic regression framework. The probability of presence $p_{ij}$ is defined as:
$\log\left(\frac{p_{ij}}{1-p_{ij}}\right) = \alpha_j + \beta_j \cdot \text{group}_i + \beta^{\text{reads}}_j \cdot \text{reads}_i + \sum \beta^{(m)}_j \cdot x^{(m)}_i$
where $\beta_j$ represents the differential prevalence (log-odds ratio) between case and control groups, $\alpha_j$ is the feature-specific intercept, and covariates include sequencing depth (log-transformed read counts) and optional confounders.
Hierarchical Priors:
- Differential Prevalence ( $\beta_j$ ): Unlike frequentist methods that treat features independently, DiPPER assumes all $\beta_j$ share a common prior distribution. The authors select an asymmetric Laplace distribution peaked at zero. This choice is motivated by the observation that most features are not differentially prevalent, and within a study, non-zero prevalence differences often share the same direction (directional imbalance).
- Hyperparameters: The scale ( $\tau_0$ ) and skewness ( $\nu_0$ ) of the asymmetric Laplace prior are governed by hyperpriors. $\tau_0$ follows a Half-Normal distribution, and $\nu_0$ follows a Laplace distribution centered at 0.50 (allowing for symmetry but permitting deviation to capture directional bias).
- Other Parameters: Feature-specific intercepts ( $\alpha_j$ ) and covariate coefficients use weakly informative Normal priors. A moderately informative prior is used for sequencing depth coefficients.
Inference: Posterior sampling is performed using the No-U-Turn Sampler (NUTS) in Stan. The method yields posterior distributions for $\beta_j$ , providing point estimates and credible intervals that are inherently adjusted for multiple testing through hierarchical shrinkage.

Key Contributions

Novel Framework: DiPPER is the first high-throughput data analysis method to employ estimation-based feature detection with a Laplace-type prior at its core, moving away from separate post-hoc multiple testing corrections.
Robustness to Boundaries: By using regularized Bayesian estimates, DiPPER provides finite point estimates and uncertainty intervals even in boundary cases (0% or 100% prevalence) where frequentist methods fail.
Directional Sensitivity: The asymmetric prior accommodates the empirical observation that differential prevalence effects in microbiome studies are often unidirectional within a study, improving sensitivity.
Benchmarking: The method was rigorously benchmarked against seven alternative methods (including frequentist logistic regression variants, MaAsLin3-DP, LDM-DP, and DAA tools MaAsLin2 and LinDA) using 57 human gut microbiome studies (80 datasets).

Results
Evaluation across 480 null datasets and 80 original datasets revealed:

Error Rate Control: DiPPER maintained a family-wise error rate (FWER) at the nominal level ( $\alpha=0.10$ ) under the global null hypothesis. In contrast, the Wald test and MaAsLin3-DP were overly conservative (low error rates but low sensitivity), while the standard Likelihood Ratio Test (LRT) had an inflated error rate.
Sensitivity and Replicability: DiPPER demonstrated high sensitivity, detecting a substantial number of significant findings. Crucially, it outperformed all competing methods in cross-study replicability. When evaluating 110 pairs of independent studies investigating the same disease, DiPPER yielded the highest number of replicated findings while minimizing conflicting results.
Boundary Handling: In illustrative examples, DiPPER successfully identified differentially prevalent features in boundary cases where frequentist methods returned non-finite results (N/A).
Comparison to DAA: DiPPER outperformed state-of-the-art DAA methods (MaAsLin2, LinDA) in terms of replicability and error rate control, reinforcing the utility of presence/absence data over full abundance profiles for detecting disease associations.

Significance and Claims
The authors claim that DiPPER offers a robust, interpretable alternative to traditional DPA and DAA. Its primary significance lies in:

Inherent Multiplicity Adjustment: It provides effect size estimates and uncertainty intervals that are naturally adjusted for multiple testing without requiring arbitrary post-hoc corrections that widen intervals and reduce precision.
Handling of Zero-Inflation: It effectively handles the boundary cases common in microbiome data without discarding potentially relevant features.
Biological Insight: The superior replication performance suggests that associations between taxonomic features and host phenotypes may be primarily driven by the presence of features rather than their abundance, and that binary data can offer a more robust signal-to-noise ratio.

The paper concludes that while the method is motivated by empirical observations from microbiome studies, its hierarchical modeling approach could potentially be extended to other omics data (transcriptomics, proteomics, etc.), though such applications require further investigation. The authors emphasize that the method's strength is its empirical grounding rather than a mechanistic model of biological processes, making it flexible for various high-throughput profiling studies.